A swollen fossil bone can tell several plausible stories. It might record a broken leg repairing itself, an infection, or a growth that disrupted healthy tissue. Its outline cannot decide which explanation is right.
One Centrosaurus leg bone had long been interpreted as a healing fracture. A later investigation changed the diagnosis to osteosarcoma, an aggressive bone cancer. The finding rests on a combination of surface examination, scans, microscopic sections, and comparisons with normal dinosaur bone and a confirmed human case. It is a case study in how to distinguish a striking shape from a defensible diagnosis.
The thumbnail is explanatory artwork. Its dinosaur, bone, and scan-like inset should not be read as photographs or diagnostic images from the research.
The specimen was already in a collection
The fossil is part of an adult Centrosaurus apertus fibula, the slender bone beside the larger lower-leg bone. It came from Dinosaur Provincial Park in Alberta in 1989. The relevant formation dates to approximately 77–75.5 million years ago, so “about 76 million years” conveys the age without pretending to know an exact year.
According to the Royal Ontario Museum’s account of the investigation, a 2017 museum visit prompted a closer examination. Specialists in paleontology, pathology, radiology, and orthopedic medicine brought different ways of reading the same specimen. The study was published in The Lancet Oncology in 2020.
The old fracture label was therefore a starting explanation to test, not a new injury observed during the later investigation. The team returned to the same preserved bone with methods that could examine its interior and tissue structure. The discovery was a change in the supported diagnosis, not a newly excavated specimen.
Extra bone does not necessarily mean repair
A healing fracture can produce a thickened mass called a callus. A bulge is therefore a reasonable reason to consider an old injury. But a diagnosis needs more than a feature that fits one possible explanation.
Osteosarcoma creates a particular problem for visual intuition because it is a malignancy associated with bone formation. As the National Cancer Institute explains, it arises from bone-forming cells in immature bone tissue. A growth can produce bone while damaging the architecture that makes a limb useful.
The important distinction is between adding material and maintaining organized structure. A larger outline does not automatically mean a stronger bone. This is why the researchers had to ask where abnormal tissue extended, what had happened to the original bone, and whether the arrangement resembled healing.
Scans located the internal disruption
The original study, “First case of osteosarcoma in a dinosaur: a multimodal diagnosis”, describes a mass occupying the upper part of the preserved segment. High-resolution CT revealed involvement of both the cortex, the dense outer wall, and the medullary region inside it.
CT builds an internal representation from X-ray measurements. It allows a researcher to follow a suspicious structure beyond the exposed surface. Here, the evidence included disruption of the cortex and highly irregular organization within the lesion, rather than orderly supporting tissue.
A scan is still an observation requiring interpretation. The authors did not treat an abnormal image as a self-explanatory cancer label. They combined the internal distribution with evidence at a finer scale. For another example of what scanning can reveal inside a fossil block, see the juvenile Doolysaurus from South Korea.
Thin sections tested the fracture explanation
Cutting a fossil into thin sections has a cost: it removes or alters unique material. It can also reveal architecture that the exterior and scans cannot settle. The team documented and cast the specimen before sectioning it.
Microscopic examination did not reveal the zoned maturation expected of a healing callus. Instead, abnormal bone extended through the original cortex and along the specimen, including regions away from the obvious swelling. That distribution made a local repair explanation difficult to sustain.
The study also considered infection and noncancerous growths. Each alternative had to explain the whole pattern, not merely the enlarged outline. This is differential diagnosis applied to a fossil: a candidate explanation becomes stronger when competing explanations fail at specific observations.
The result is not a claim that ancient tumor cells were revived. The diagnosis concerns preserved tissue architecture and the effects of disease on bone. Those effects can remain recognizable after the living cells and soft tissues are gone.
Why compare it with a human bone?
A normal Centrosaurus fibula supplied a comparison within the same species. A human fibula with medically confirmed osteosarcoma supplied a well-understood example of destructive, abnormal bone growth. McMaster University’s description of the work explains that the human specimen was scanned with microCT so its structure could be compared with the fossil and pathology sections.
The comparison does not make humans close dinosaur relatives. The study explicitly recognizes the greater evolutionary proximity of birds and reptiles. Its value lies in the established diagnosis and specialist knowledge available in human medicine. The fossil still needed its own anatomical and microscopic evidence.
Together, these approaches supported the reported first confirmed case of osteosarcoma in a dinosaur. “First confirmed” describes the evidence available to researchers, not the first time the disease ever occurred.
Diagnosis, death, and herd life are different questions
The extensive invasion suggests the animal lived with the disease for a substantial period. A precise duration cannot be calculated from this bone. Nor can the specimen reveal an exact limp or a measured intensity of pain.
The researchers suggested that cancer might have spread to other body systems. That is a possibility consistent with advanced osteosarcoma, rather than a preserved observation of metastases in another organ. The National Cancer Institute’s description of spread in living patients helps explain the possibility; it cannot establish what happened throughout this dinosaur’s body.
Cancer also need not have caused its death. The museum account places the fossil in a large Centrosaurus bonebed interpreted as a herd killed by a flood. It proposes that herd membership may have helped a vulnerable animal survive longer. That is not evidence of companions deliberately feeding or nursing it.
Finally, one diagnosed individual cannot reveal how common cancer was among dinosaurs. Soft tissues are usually lost, unusual bones may never be scanned, and destructive analysis is not undertaken casually. Those filters limit discovery. They justify uncertainty about frequency, rather than proving either that cancer was rare or that it was widespread. The durable conclusion is narrower: this individual had a recognizable malignant bone disease, and several kinds of evidence explain why the diagnosis changed.
